Sorrento Therapeutics, Inc.
- SEC CIK
- 0000850261
No open-market purchases or sales filed in the past year.
Current role at each company
- CELU Celularity Inc10% Owneras of Oct 5, 2023
- SCLX Scilex Holding Co10% Owneras of Sep 25, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sorrento Therapeutics, Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CELU Celularity Inc
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2023 (view filing) | Sep 29-Oct 5 | 6 daysLate | Sorrento Therapeutics, Inc.10% Owner | SSaleClass A Common Stock | −15.4M | – | – | −75.3%5.05M after | 2 lots |
SCLX Scilex Holding Co
10% Owner6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 (view filing) | Sep 21 | 4 days | Sorrento Therapeutics, Inc.10% Owner | SSale | −60.1M | – | – | −96.9%1.92M after | |
| Sep 25, 2023 (view filing) | Sep 21 | 4 days | Sorrento Therapeutics, Inc.10% Owner | SSale | −4.49M | – | – | –0 after | Derivative |
| Dec 2, 2022 (view filing)7:21 PM ET | Dec 2 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +224.8K | $0.3507 | +$78.9K | –4.49M after | Derivative |
| Nov 25, 2022 (view filing)3:21 PM ET | Nov 25 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +46.2K | $0.4374 | +$20.2K | –4.27M after | Derivative |
| Nov 23, 2022 (view filing)5:59 PM ET | Nov 23 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +442.8K | $0.3967 | +$175.7K | –4.22M after | Derivative |
| Nov 22, 2022 (view filing)7:24 PM ET | Nov 22 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +672.8K | $0.226 | +$152.0K | –3.78M after | Derivative |